Search Results - "Valimaki, Katja"
-
1
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
Published in Scientific reports (14-11-2017)“…The paradigm of molecular histopathology is shifting from a single-marker immunohistochemistry towards multiplexed detection of markers to better understand…”
Get full text
Journal Article -
2
Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma
Published in Frontiers in oncology (20-06-2022)“…Background Pleural mesothelioma (MPM) is an aggressive malignancy with an average patient survival of only 10 months. Interestingly, about 5%–10% of the…”
Get full text
Journal Article -
3
ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity
Published in Cell death discovery (03-07-2023)“…Wnt pathway dysregulation through genetic and non-genetic alterations occurs in multiple cancers, including ovarian cancer (OC). The aberrant expression of the…”
Get full text
Journal Article -
4
High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
Published in Translational oncology (01-01-2022)“…•We established patient-derived cancer cell (PDC) lines from NRAS-positive MM tumors.•We carried out high-throughput drug testing with PDCs against 527…”
Get full text
Journal Article -
5
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival
Published in Blood advances (28-01-2020)“…The immunologic microenvironment in various solid tumors is aberrant and correlates with clinical survival. Here, we present a comprehensive analysis of the…”
Get full text
Journal Article -
6
High tumor cell platelet‐derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma
Published in The journal of pathology. Clinical research (01-09-2021)“…Malignant pleural mesothelioma (MPM) has a rich stromal component containing mesenchymal fibroblasts. However, the properties and interplay of MPM tumor cells…”
Get full text
Journal Article -
7
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
Published in The journal of pathology. Clinical research (01-01-2019)“…Tumour budding predicts survival of stage II colorectal cancer (CRC) and has been suggested to be associated with epithelial‐to‐mesenchymal transition (EMT)…”
Get full text
Journal Article -
8
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
Published in British journal of cancer (16-02-2023)“…Many efforts are underway to develop novel therapies against the aggressive high-grade serous ovarian cancers (HGSOCs), while our understanding of treatment…”
Get full text
Journal Article -
9
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features
Published in JNCI : Journal of the National Cancer Institute (2023)“…Cancer-associated fibroblasts (CAFs) are molecularly heterogeneous mesenchymal cells that interact with malignant cells and immune cells and confer anti- and…”
Get full text
Journal Article -
10
E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Published in Molecular oncology (01-06-2022)“…Cell–cell and cell–matrix adhesion proteins that have been implicated in colorectal epithelial integrity and epithelial‐to‐mesenchymal transition could be…”
Get full text
Journal Article -
11
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses
Published in Oncoimmunology (2024)“…Immunotherapy has emerged as a promising approach for cancer treatment, with oncolytic adenoviruses showing power as immunotherapeutic agents. In this study,…”
Get full text
Journal Article -
12
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma
Published in Communications biology (20-10-2024)“…Clear-cell renal cell carcinoma (ccRCC) is the most common origin of pancreatic metastases (PM). Distinct genomic aberrations, favorable prognosis, and…”
Get full text
Journal Article -
13
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
Published in Scientific reports (05-02-2018)“…Caveolin-1 (CAV1) is over-expressed in prostate cancer (PCa) and is associated with adverse prognosis, but the molecular mechanisms linking CAV1 expression to…”
Get full text
Journal Article -
14
Abstract 5490: Spatial profiling of inflamed tumor microenvironment of clear cell renal cell carcinoma
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Clear cell renal cell carcinoma (ccRCC) presents a distinctive tumor microenvironment (TME) characterized by extensive vascularization and immune…”
Get full text
Journal Article -
15
Abstract 892: Pan-cancer tumor microenvironment profiling with multiplexed immunofluorescence microscopy and self-supervised learning
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Multiplexed immunofluorescence (mIF) microscopy reveals the spatial architecture of cancer tissue and its microenvironment that is not being fully…”
Get full text
Journal Article -
16
Abstract 299: FAP/αSMA association with tumor visibility and progression in prostate cancer
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Introduction Prostate cancer (PCa) ranks as the second most frequently diagnosed cancer in the male population worldwide. The challenge in effectively…”
Get full text
Journal Article -
17
Abstract 2945: Clinical implementation of precision systems oncology in the treatment of ovarian cancer based on ex-vivo drug testing and molecular profiling
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Ovarian cancer (OC) is difficult to treat and has a high mortality rate. There is a strong need for new therapies, but OC is often not the main…”
Get full text
Journal Article -
18
Quantitative Multiplex Immunohistochemistry Identifies Immunosuppression in the AML Bone Marrow and NK-Cells As Prognostic Biomarker in Intermediate-Risk Patients
Published in Blood (29-11-2018)“…BACKGROUND A complex interaction between blasts and surrounding cells in the acute myeloid leukemia (AML) bone marrow (BM) microenvironment sustains blast…”
Get full text
Journal Article -
19
Abstract 4459: Spatial profiling of the inflamed tumor microenvironment identifies novel prognostic subclasses in non-metastatic clear cell renal carcinoma patients
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract INTRODUCTION: Clear cell renal cell carcinoma (ccRCC) is highly vascularized and inflamed, and RNA signatures of angiogenesis/inflammation have been…”
Get full text
Journal Article -
20
Abstract 2091: Open-source single-cell spatial image analysis pipeline for ten-plex immunofluorescence of histological prostate cancer tissue sections
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Introduction: Multiplexed fluorescence immunohistochemistry (mfIHC) allows the detection of multiple protein markers on the same histological tissue…”
Get full text
Journal Article